Unlock stock picks and a broker-level newsfeed that powers Wall Street.
XETRA - Delayed Quote EUR

Atai Life Sciences N.V. (9VC.DE)

Compare
1.1820
-0.0130
(-1.09%)
At close: April 4 at 5:35:31 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue -5k
Earnings -38.96M

Q1'24

Q2'24

Q3'24

Q4'24

-40M
-20M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5566
Avg. Estimate ----250k250k
Low Estimate --------
High Estimate ----1.5M1.5M
Year Ago Sales --273k308k250k
Sales Growth (year/est) 0.00%-100.00%-18.83%0.00%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
9VC.DE --------
S&P 500 6.57%6.54%9.73%14.28%

Upgrades & Downgrades

Reiterates HC Wainwright & Co.: Buy to Buy 3/19/2025
Reiterates HC Wainwright & Co.: Buy to Buy 2/13/2025
Maintains HC Wainwright & Co.: Buy to Buy 11/18/2024
Maintains Canaccord Genuity: Buy to Buy 11/18/2024

Related Tickers